A novel cancer vaccine targeting HER2-positive malignancies has progressed quickly from mouse trials into early-phase human trials, with promising results.
Dianne Shumay, PhD, director of psycho-oncology at UCSF, weighs in on how we can use psychological interventions to improve stress levels in cancer patients.
Plasma fibrinogen tests should be encouraged routinely in clinical practice to clarify its predictive benefit, according to a study.
A study shows undergoing treatment for DLBCL at a clinic with more experience was linked with important clinical outcomes.
The FDA authorized the first next-generation sequencing test to detect minimal residual disease in blood cancers.
A study shows gene variants of uncertain significance are frequently reclassified, necessitating amended test result reports.
Minimal residual disease negativity measured by next-generation sequencing was a valuable prognostic biomarker for multiple myeloma.
Different cytotoxic chemotherapy regimens are associated with varying rates of hospitalization following their use in older women with stage IV breast cancer.
The percentage of patients with pediatric melanoma is 6-fold to the 28-fold higher when compared with the general population of patients with melanoma.
A study shows stress may affect certain cellular, cytokine, and chemokine markers in the body of patients with CLL.